In focus · trending topic

Acute Myeloid Leukemia

114 stories · following the connections

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

By Nasdaq OMXMay 31, 2017, 11:36 AM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A

By Nasdaq OMXMay 24, 2017, 1:26 PM UTC

Actinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha Therapy

By Nasdaq OMXMay 23, 2017, 11:32 AM UTC